Discovery of potential WEE1 inhibitors via hybrid virtual screening

Tingting Jin(Sir Run Run Shaw Hospital), Bo Zhang(Hangzhou First People's Hospital), Zheyuan Shen(Second Affiliated Hospital of Zhejiang University), Roufen Chen(Zhejiang Lab), Lei Xu(Chinese Academy of Sciences), Wei Xu(First Affiliated Hospital of Harbin Medical University), Lixin Zhou(Peking University), Nengming Lin(Hangzhou First People's Hospital), Jian Gao(Zhejiang University), Liteng Shen(Zhejiang Lab), Xinglong Chi(State Key Laboratory of Natural Medicine)
Frontiers in Pharmacology
December 7, 2023
10.3389/fphar.2023.1298245
Cited by 8

Related Papers

Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer
|Modern Pathology|2021|87
ADCdb: the database of antibody–drug conjugates
|Nucleic Acids Research|2023|69
Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases
|Food and Chemical Toxicology|2016|53
Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation
|Journal of Advanced Research|2021|45
Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
|Frontiers in Pharmacology|2020|44